Renovis: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Renovis is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics in the areas of neurological and inflammatory diseases. Using its proprietary drug discovery capabilities in medicinal chemistry, cell biology and chemical screening libraries, the company is discovering and developing drug candidates internally as well as with strategic partners.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Renovis, a small molecule drug discovering and developing company, has proprietary pipeline products such as P2X7 and P2X3 antagonists for pain that are in preclinical development stage. The company has collaborated with Pfizer for developing VR1 antagonist for the treatment of pain.

    During 2002-2006, the company recorded all of its revenues under collaborative agreements with. Pfizer for VR1 program and AstraZeneca for NXY-059, which was suspended in 2006 on failing to meet the primary end points.

    The total revenues increased from $5 million in 2003 to $10 million in 2006, primarily due to the increased upfront fees and milestone payments received from collaborative partners.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: renovis p2x3 antagonist fraley george chemical company balance farrow sheet

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.